Obesity, GLP-1s, and the Evidence: What the Data Tells Us

Obesity, GLP-1s, and the Evidence: What the Data Tells Us

In this second episode of our obesity series, preventive cardiologist Neha Pagidipati sheds light on the discovery, impact, and uses of GLP-1s, like Ozempic and Mounjaro. Learn about the impact these medications are having on diabetes, heart disease, and weight management. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-4-obesity-glp-1s-and-evidence-what-data-tells-us

Avsnitt(47)

Populärt inom Vetenskap

dumma-manniskor
p3-dystopia
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
svd-nyhetsartiklar
rss-vetenskapsradion
det-morka-psyket
rss-spraket
rss-ufo-bortom-rimligt-tvivel-2
rss-vetenskapsradion-2
sexet
paranormalt-med-caroline-giertz
hacka-livet
rss-tidslinjen-podcast
medicinvetarna
dumforklarat
halsorevolutionen
vetenskap-och-halsa
har-vi-akt-till-mars-an
doden-hjarnan-kemisten